GlaxoSmithKline, LLC. Recall: Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneo
GlaxoSmithKline, LLC. Recall: Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneo is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: GlaxoSmithKline, LLC.; Product: Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneous injection only, Rx only, 2 Single-Dose Syringe Cartr
| Recalling firm | GlaxoSmithKline, LLC. |
|---|---|
| Product | Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneous injection only, Rx only, 2 Single-Dose Syringe Cartridges for use with sumatriptan Autoinjector Pen, Manufactured by GlaxoSmithKline, Research Triangle Park, NC 27709 for Sandoz Inc., Princeton, NJ 08540, Made in Singapore, NDC 0781-3173-07. |
| Reason for recall | Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide |
| Recall initiated | 20131106 |
| Recall number | D-388-2014 |
| Category | drug |
| State | NC |
| Country | United States |
$29/mo
Try RecallGuard →